Park, Eun-Yeong
Baik, Jinwoo
Kim, Hyojin
Park, Sung-Min
Kim, Chulhong
Funding for this research was provided by:
Daewoong Pharmaceutical Company (DF-201901-0000001)
Samsung Advanced Institute of Technology
National Research Foundation of Korea (NRF-2019R1A2C2006269)
Korea Health Industry Development Institute (HI15C1817)
Article History
Received: 19 February 2020
Accepted: 27 July 2020
First Online: 7 August 2020
Competing interests
: Chulhong Kim has financial interests in OPTICHO, which, however, did not support this work. Eun-Yeong Park, Jinwoo Baik, Hyojin Kim, and Sung-Min Park declare no potential conflict of interest.